BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10620552)

  • 1. In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.
    Mackenzie RK; Jones S; Moseley A; Holmes CJ; Argyle R; Williams JD; Coles GA; Pu K; Faict D; Topley N
    Am J Kidney Dis; 2000 Jan; 35(1):112-21. PubMed ID: 10620552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
    Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
    MacKenzie RK; Holmes CJ; Moseley A; Jenkins JP; Williams JD; Coles GA; Faict D; Topley N
    J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Fischer FP; Schenk U; Kiefer T; Hübel E; Thomas S; Yatzidis H; Mettang T; Kuhlmann U
    Am J Kidney Dis; 1995 Dec; 26(6):924-33. PubMed ID: 7503067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
    Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
    Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bicarbonate-based dialysis solutions on intracellular pH (pHi) and TNFalpha production by peritoneal macrophages.
    Rogachev B; Hausmann MJ; Yulzari R; Weiler M; Holmes C; Faict D; Chaimovitz C; Douvdevani A
    Perit Dial Int; 1997; 17(6):546-53. PubMed ID: 9655153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
    de Fijter CW; Verbrugh HA; Peters ED; Oe PL; van der Meulen J; Verhoef J; Donker AJ
    Clin Nephrol; 1993 Feb; 39(2):75-80. PubMed ID: 8448921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
    Selgas R; Bajo MA; Fernandez-Reyes MJ; Jimenez C; Del Peso G; Sanchez C; de Alvaro F
    Adv Perit Dial; 1996; 12():49-52. PubMed ID: 8865872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
    Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
    Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Barocci S; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():110-3. PubMed ID: 1982785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
    Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions.
    Pajek J; Kveder R; Gucek A; Skoberne A; Bren A; Bucar M; Cerne D; Lukac-Bajalo J
    Ther Apher Dial; 2010 Feb; 14(1):20-6. PubMed ID: 20438516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.